123I-间碘苄胍心肌显像诊断路易体病的尸检验证
该回顾性横断面研究纳入56例尸检患者(30例病理确诊路易体病,26例无路易体病病理),以尸检为金标准验证123I-间碘苄胍心肌显像的诊断准确性。延迟H/M比值的敏感度和特异度分别为80.0%和92.3%,洗脱率分别为80.0%和84.6%。研究提供II级证据表明该显像可准确识别路易体病患者。
要点
- 延迟H/M比值诊断路易体病的敏感度80.0%、特异度92.3%。
- 洗脱率诊断路易体病的敏感度80.0%、特异度84.6%。
- 心肌交感神经纤维残留比例与早期和延迟H/M比值强相关(相关系数0.75和0.81,p<0.001)。
核心结论
- 123I-间碘苄胍心肌显像可强有力地鉴别路易体病与相似疾病,异常显像结果强烈支持路易体病和心脏交感神经去神经支配的存在。
- 正常心肌显像结果不应必然排除路易体病病理,尤其当其他生物标志物提示存在共病阿尔茨海默病病理时。
研究设计与样本
- 回顾性横断面研究,纳入脑老化研究脑库中连续接受过123I-间碘苄胍心肌显像的尸检患者。
- 共分析56例患者,其中30例病理确诊路易体病,26例无路易体病病理。
- 将123I-间碘苄胍心肌显像结果与尸检结果进行比较,并检测左心室前壁酪氨酸羟化酶免疫反应性交感神经纤维残留比例。
主要发现
- 与神经病理诊断相比,早期H/M比值的敏感度和特异度分别为70.0%(95%CI 50.6%-85.3%)和96.2%(95%CI 80.4%-99.9%)。
- 延迟H/M比值的敏感度和特异度分别为80.0%(95%CI 61.4%-92.3%)和92.3%(95%CI 74.9%-99.1%)。
- 洗脱率的敏感度和特异度分别为80.0%(95%CI 61.4%-92.3%)和84.6%(95%CI 65.1%-95.6%)。
- 左心室前壁酪氨酸羟化酶免疫反应性交感神经纤维残留比例与早期和延迟H/M比值评估的心脏123I-间碘苄胍摄取量强相关(相关系数分别为0.75和0.81;p<0.001)。
关键数值与推荐
- 早期H/M比值诊断路易体病:敏感度70.0%(95%CI 50.6%-85.3%),特异度96.2%(95%CI 80.4%-99.9%)。
- 延迟H/M比值诊断路易体病:敏感度80.0%(95%CI 61.4%-92.3%),特异度92.3%(95%CI 74.9%-99.1%)。
- 洗脱率诊断路易体病:敏感度80.0%(95%CI 61.4%-92.3%),特异度84.6%(95%CI 65.1%-95.6%)。
临床怎么用
- 本研究提供II级证据表明123I-间碘苄胍心肌显像可准确识别路易体病患者。
- 异常123I-间碘苄胍心肌显像结果强烈支持路易体病和心脏交感神经去神经支配的存在。
- 正常心肌显像结果不应必然排除路易体病病理,尤其当其他生物标志物提示存在共病阿尔茨海默病病理时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: 123I-meta-iodobenzyl-guanidine (123I-MIBG) myocardial scintigraphy is used as a diagnostic imaging test to differentiate Lewy body diseases (LBDs), including Parkinson disease and dementia with Lewy bodies, from other similar diseases. However, this imaging test lacks validation of its diagnostic accuracy against the gold standard. Our aim was to validate the diagnostic accuracy of 123I-MIBG myocardial scintigraphy for LBD against autopsy, the gold standard. METHODS: This retrospective, cross-sectional study included consecutive autopsy patients from the Brain Bank for Aging Research who had undergone 123I-MIBG myocardial scintigraphy. We compared the 123I-MIBG myocardial scintigraphy findings with autopsy findings. Furthermore, the proportion of residual tyrosine hydroxylase (TH)-immunoreactive sympathetic fibers in the anterior wall of the left ventricle was investigated to assess the condition of the cardiac sympathetic nerves assumed to cause reduced 123I-MIBG uptake in LBDs. RESULTS: We analyzed the data of 56 patients (30 with pathologically confirmed LBDs and 26 without LBD pathology). Compared with the neuropathologic diagnosis, the early heart-to-mediastinum (H/M) ratio had a sensitivity and specificity of 70.0% (95% CI 50.6%-85.3%) and 96.2% (95% CI 80.4%-99.9%), respectively. The delayed H/M ratio had a sensitivity and specificity of 80.0% (95% CI 61.4%-92.3%) and 92.3% (95% CI 74.9%-99.1%), respectively. The washout rate had a sensitivity and specificity of 80.0% (95% CI 61.4%-92.3%) and 84.6% (95% CI 65.1%-95.6%), respectively. The proportion of residual TH-immunoreactive cardiac sympathetic fibers strongly correlated with the amount of cardiac 123I-MIBG uptake when assessed with early and delayed H/M ratio values (correlation coefficient 0.75 and 0.81, respectively; p < 0.001). DISCUSSION: This clinicopathologic validation study revealed that 123I-MIBG myocardial scintigraphy could robustly differentiate LBDs from similar diseases. Abnormal 123I-MIBG myocardial scintigraphy findings strongly support the presence of LBD and cardiac sympathetic denervation. However, LBD pathology should not necessarily be excluded by normal myocardial scintigraphy results, especially when other biomarkers suggest the presence of comorbid Alzheimer disease pathology. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that 123I-MIBG myocardial scintigraphy accurately identifies patients with LBD.
引用
- Matsubara T, Kameyama M, Tanaka N, et al. Autopsy Validation of the Diagnostic Accuracy of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease. Neurology. 2022. PMID: 35256483. doi:10.1212/WNL.0000000000200110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。